nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—Depressive symptom—Lisinopril—dilated cardiomyopathy	0.0646	0.101	CcSEcCtD
Rimonabant—CYP2C9—cardial valve—dilated cardiomyopathy	0.0523	0.746	CbGeAlD
Rimonabant—Lethargy—Spironolactone—dilated cardiomyopathy	0.0256	0.0402	CcSEcCtD
Rimonabant—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0226	0.0355	CcSEcCtD
Rimonabant—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0217	0.0341	CcSEcCtD
Rimonabant—CNR1—heart—dilated cardiomyopathy	0.0149	0.213	CbGeAlD
Rimonabant—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0145	0.0228	CcSEcCtD
Rimonabant—Lethargy—Furosemide—dilated cardiomyopathy	0.0139	0.0219	CcSEcCtD
Rimonabant—CNR1—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0137	0.0467	CbGpPWpGaD
Rimonabant—Irritability—Furosemide—dilated cardiomyopathy	0.013	0.0204	CcSEcCtD
Rimonabant—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0123	0.0193	CcSEcCtD
Rimonabant—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0118	0.0186	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0116	0.0394	CbGpPWpGaD
Rimonabant—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0115	0.0181	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0106	0.0167	CcSEcCtD
Rimonabant—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.0105	0.0165	CcSEcCtD
Rimonabant—CNR1—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.0104	0.0355	CbGpPWpGaD
Rimonabant—Irritability—Lisinopril—dilated cardiomyopathy	0.00977	0.0153	CcSEcCtD
Rimonabant—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00921	0.0145	CcSEcCtD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00907	0.0309	CbGpPWpGaD
Rimonabant—Influenza—Lisinopril—dilated cardiomyopathy	0.00884	0.0139	CcSEcCtD
Rimonabant—Pruritus—Spironolactone—dilated cardiomyopathy	0.00872	0.0137	CcSEcCtD
Rimonabant—Angiopathy—Furosemide—dilated cardiomyopathy	0.00856	0.0134	CcSEcCtD
Rimonabant—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00843	0.0132	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00822	0.0129	CcSEcCtD
Rimonabant—Malnutrition—Furosemide—dilated cardiomyopathy	0.00821	0.0129	CcSEcCtD
Rimonabant—CNR1—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00815	0.0278	CbGpPWpGaD
Rimonabant—Dizziness—Spironolactone—dilated cardiomyopathy	0.00815	0.0128	CcSEcCtD
Rimonabant—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0079	0.0124	CcSEcCtD
Rimonabant—Depression—Lisinopril—dilated cardiomyopathy	0.00786	0.0124	CcSEcCtD
Rimonabant—Vomiting—Spironolactone—dilated cardiomyopathy	0.00783	0.0123	CcSEcCtD
Rimonabant—Rash—Spironolactone—dilated cardiomyopathy	0.00777	0.0122	CcSEcCtD
Rimonabant—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00776	0.0122	CcSEcCtD
Rimonabant—Headache—Spironolactone—dilated cardiomyopathy	0.00772	0.0121	CcSEcCtD
Rimonabant—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0074	0.0116	CcSEcCtD
Rimonabant—Nausea—Spironolactone—dilated cardiomyopathy	0.00732	0.0115	CcSEcCtD
Rimonabant—Hallucination—Lisinopril—dilated cardiomyopathy	0.00704	0.0111	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00694	0.0109	CcSEcCtD
Rimonabant—Dry mouth—Furosemide—dilated cardiomyopathy	0.00684	0.0107	CcSEcCtD
Rimonabant—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00657	0.0103	CcSEcCtD
Rimonabant—Skin disorder—Furosemide—dilated cardiomyopathy	0.00651	0.0102	CcSEcCtD
Rimonabant—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00648	0.0102	CcSEcCtD
Rimonabant—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00642	0.0101	CcSEcCtD
Rimonabant—CNR1—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.0064	0.0218	CbGpPWpGaD
Rimonabant—Anorexia—Furosemide—dilated cardiomyopathy	0.00639	0.01	CcSEcCtD
Rimonabant—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00638	0.01	CcSEcCtD
Rimonabant—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0062	0.00974	CcSEcCtD
Rimonabant—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00616	0.00968	CcSEcCtD
Rimonabant—Tension—Lisinopril—dilated cardiomyopathy	0.00605	0.0095	CcSEcCtD
Rimonabant—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00602	0.00946	CcSEcCtD
Rimonabant—Nervousness—Lisinopril—dilated cardiomyopathy	0.00599	0.0094	CcSEcCtD
Rimonabant—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00592	0.00931	CcSEcCtD
Rimonabant—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00583	0.00915	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00579	0.00909	CcSEcCtD
Rimonabant—Fatigue—Furosemide—dilated cardiomyopathy	0.00578	0.00908	CcSEcCtD
Rimonabant—Tremor—Lisinopril—dilated cardiomyopathy	0.00577	0.00907	CcSEcCtD
Rimonabant—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00548	0.00861	CcSEcCtD
Rimonabant—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0053	0.00832	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00523	0.0178	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00523	0.0178	CbGpPWpGaD
Rimonabant—Anxiety—Lisinopril—dilated cardiomyopathy	0.00523	0.00821	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00521	0.00819	CcSEcCtD
Rimonabant—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00513	0.00806	CcSEcCtD
Rimonabant—Infection—Lisinopril—dilated cardiomyopathy	0.005	0.00785	CcSEcCtD
Rimonabant—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00489	0.00767	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00486	0.0166	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00486	0.00764	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00486	0.0166	CbGpPWpGaD
Rimonabant—Asthenia—Furosemide—dilated cardiomyopathy	0.00481	0.00756	CcSEcCtD
Rimonabant—Anorexia—Lisinopril—dilated cardiomyopathy	0.00479	0.00753	CcSEcCtD
Rimonabant—Pruritus—Furosemide—dilated cardiomyopathy	0.00474	0.00745	CcSEcCtD
Rimonabant—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00459	0.00721	CcSEcCtD
Rimonabant—Insomnia—Lisinopril—dilated cardiomyopathy	0.00455	0.00715	CcSEcCtD
Rimonabant—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00452	0.00709	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00451	0.0154	CbGpPWpGaD
Rimonabant—Dizziness—Furosemide—dilated cardiomyopathy	0.00443	0.00696	CcSEcCtD
Rimonabant—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00437	0.00687	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00437	0.0149	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00434	0.00682	CcSEcCtD
Rimonabant—Fatigue—Lisinopril—dilated cardiomyopathy	0.00434	0.00681	CcSEcCtD
Rimonabant—Vomiting—Furosemide—dilated cardiomyopathy	0.00426	0.0067	CcSEcCtD
Rimonabant—Rash—Furosemide—dilated cardiomyopathy	0.00423	0.00664	CcSEcCtD
Rimonabant—Dermatitis—Furosemide—dilated cardiomyopathy	0.00422	0.00663	CcSEcCtD
Rimonabant—Headache—Furosemide—dilated cardiomyopathy	0.0042	0.0066	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00416	0.0142	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00416	0.0142	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00411	0.00646	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00411	0.014	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00411	0.014	CbGpPWpGaD
Rimonabant—Nausea—Furosemide—dilated cardiomyopathy	0.00398	0.00626	CcSEcCtD
Rimonabant—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00398	0.00625	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00387	0.0132	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00382	0.013	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00381	0.013	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00381	0.013	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00375	0.0128	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00373	0.0127	CbGpPWpGaD
Rimonabant—Asthenia—Lisinopril—dilated cardiomyopathy	0.00361	0.00567	CcSEcCtD
Rimonabant—Pruritus—Lisinopril—dilated cardiomyopathy	0.00356	0.00559	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00354	0.0121	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00354	0.0121	CbGpPWpGaD
Rimonabant—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00344	0.00541	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00344	0.0117	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00343	0.0117	CbGpPWpGaD
Rimonabant—Dizziness—Lisinopril—dilated cardiomyopathy	0.00333	0.00522	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00326	0.0111	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00326	0.0111	CbGpPWpGaD
Rimonabant—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00321	0.011	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0032	0.0109	CbGpPWpGaD
Rimonabant—Vomiting—Lisinopril—dilated cardiomyopathy	0.0032	0.00502	CcSEcCtD
Rimonabant—Rash—Lisinopril—dilated cardiomyopathy	0.00317	0.00498	CcSEcCtD
Rimonabant—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00317	0.00498	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00317	0.0108	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00317	0.0108	CbGpPWpGaD
Rimonabant—Headache—Lisinopril—dilated cardiomyopathy	0.00315	0.00495	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00303	0.0103	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00303	0.0103	CbGpPWpGaD
Rimonabant—Nausea—Lisinopril—dilated cardiomyopathy	0.00299	0.00469	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00295	0.01	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00294	0.01	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00293	0.00999	CbGpPWpGaD
Rimonabant—CYP2C9—heart—dilated cardiomyopathy	0.00289	0.0412	CbGeAlD
Rimonabant—CNR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00285	0.00972	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00283	0.00965	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00278	0.00947	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00272	0.00928	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00251	0.00856	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00249	0.00847	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00249	0.00847	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00244	0.0083	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00238	0.00812	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00231	0.00788	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00231	0.00788	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00228	0.00778	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00225	0.00767	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00224	0.00763	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00222	0.00757	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00191	0.00652	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00181	0.00618	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00179	0.0061	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00179	0.0061	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00177	0.00602	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00171	0.00584	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00166	0.00567	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00163	0.00554	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00163	0.00554	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00161	0.00549	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00151	0.00515	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00146	0.00499	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00141	0.00481	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0014	0.00479	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0014	0.00479	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00138	0.00469	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00135	0.00458	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00131	0.00445	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00131	0.00445	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00128	0.00435	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00128	0.00435	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00126	0.00431	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00126	0.00428	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00125	0.00426	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00121	0.00411	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00119	0.00404	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00119	0.00404	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00115	0.00392	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00108	0.00369	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00108	0.00368	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00102	0.00349	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00101	0.00346	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000981	0.00334	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000969	0.0033	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00096	0.00327	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00096	0.00327	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000931	0.00317	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000921	0.00314	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000893	0.00304	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00088	0.003	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000874	0.00298	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000865	0.00295	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000849	0.00289	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000821	0.0028	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000796	0.00271	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000785	0.00268	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00076	0.00259	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000754	0.00257	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000754	0.00257	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000747	0.00254	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000739	0.00252	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000723	0.00246	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000702	0.00239	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000701	0.00239	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000701	0.00239	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00069	0.00235	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000679	0.00231	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000611	0.00208	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000602	0.00205	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00058	0.00198	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00055	0.00187	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000544	0.00185	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000538	0.00183	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000538	0.00183	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.00052	0.00177	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000513	0.00175	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000513	0.00175	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000479	0.00163	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000472	0.00161	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000427	0.00145	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000419	0.00143	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000408	0.00139	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000392	0.00134	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000389	0.00133	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000369	0.00126	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000366	0.00125	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000361	0.00123	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000334	0.00114	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000332	0.00113	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000331	0.00113	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000329	0.00112	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000313	0.00107	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000283	0.000965	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000283	0.000964	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000257	0.000875	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000247	0.000843	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000241	0.000822	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000218	0.000744	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000202	0.000688	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000197	0.00067	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000194	0.000661	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000177	0.000603	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000172	0.000588	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000168	0.000572	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000151	0.000515	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	9.07e-05	0.000309	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.99e-05	0.000306	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.83e-05	0.000301	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.75e-05	0.000298	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7.95e-05	0.000271	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.88e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	7.68e-05	0.000262	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.48e-05	0.000255	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.73e-05	0.00023	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.93e-05	0.000202	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.77e-05	0.000197	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.2e-05	0.000177	CbGpPWpGaD
